We demonstrate cooperativity between both drugs in two AML cell lines, one—U937—with mutated TP53, the other—MOLM-13—with wildtype TP53, regarding inhibition of proliferation, induction of cell death, and coordinate regulation of more than 1200 transcripts (the majority becoming derepressed). The gene discussed is TP53; the disease is acute myeloid leukemia.